Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

The Effect of Ranolazine on Echocardiographic Indices of Diastolic Dysfunction

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00574756
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:37:12.946884+00:00
Published At
2019-08-02T00:00:00+00:00
Record Updated At
2019-08-02
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Ranolazine", "Diastolic Heart Failure", "Tissue Doppler Ultrasound", "Echocardiography"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2019-08-02"
protocolSection.identificationModule.nctId
"NCT00574756"
protocolSection.identificationModule.officialTitle
"The Effect of Ranolazine on Echocardiographic Indices of Diastolic Dysfunction"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Ranolazine (protocolSection.conditionsModule.conditions)
  • Diastolic Heart Failure (protocolSection.conditionsModule.conditions)
  • Tissue Doppler Ultrasound (protocolSection.conditionsModule.conditions)
  • Echocardiography (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.